Medco Health Solutions Faces Second DoJ Probe In Five Years; Latest Involves AstraZeneca
This article was originally published in The Pink Sheet Daily
Executive Summary
Medco Health Solutions and AstraZeneca have received subpoenas from the DoJ for information involving arrangements pertaining to four AstraZeneca drugs.